Isothiazole-4-carboxylic acid, 95.0%, 100mg

(E)-N-(4-((4-Fluorophenyl)amino)-7-methoxyquinazolin-6-yl)-4-(piperidin-1-yl)but-2-enamide (Dacomitinib Impurity), 97%, 50mg

3-[(Cyclopentylcarbonyl)amino]benzoic acid, 95.0%, 1g

2-Bromo-4-pyridinecarboxylic acid, 98.0%, 10g

Hydrochloric acid 32%, extra pure, 2.5 l, plastic packaging.

6-(trifluoromethyl)-2H-pyrazolo[4,3-b]pyridin-3-amine, 95%, 5g

3-(2-Methylpiperidin-1-yl)propan-1-amine, 95.0%, 500ml

(R)-2-((tert-butoxycarbonyl)amino)-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propanoic acid, 97%, 250mg

6-Methylquinolin-4-ol, 95.0%, 25g

20(R)-Ginsenoside Rh2>97.0%(HPLC)5mg

2-Methoxy-4,6-dimethylnicotinonitrile, 95.0%, 25g

(3aS,6aS)-Benzyl 5-oxohexahydropyrrolo[3,2-b]pyrrole-1(2H)-carboxylate, 96%, 1g

3-(2-Bromoacetyl)pyridine, 95.0%, 250mg